MQS Management LLC Invests $249,000 in Option Care Health, Inc. (NASDAQ:OPCH)

MQS Management LLC bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 9,000 shares of the company’s stock, valued at approximately $249,000.

Other hedge funds have also added to or reduced their stakes in the company. Principal Securities Inc. bought a new stake in Option Care Health during the 4th quarter worth about $27,000. Parallel Advisors LLC raised its holdings in Option Care Health by 130.2% during the fourth quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after acquiring an additional 478 shares in the last quarter. TFO Wealth Partners LLC raised its holdings in Option Care Health by 24,625.0% during the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after acquiring an additional 985 shares in the last quarter. Park Place Capital Corp boosted its position in Option Care Health by 48.4% during the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock valued at $38,000 after purchasing an additional 372 shares during the last quarter. Finally, SageView Advisory Group LLC bought a new position in Option Care Health in the first quarter valued at approximately $85,000. Institutional investors own 98.05% of the company’s stock.

Insiders Place Their Bets

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Option Care Health Trading Up 1.1 %

Option Care Health stock opened at $31.90 on Friday. The stock has a 50-day simple moving average of $31.20 and a 200 day simple moving average of $30.47. The stock has a market capitalization of $5.54 billion, a P/E ratio of 20.99, a PEG ratio of 2.46 and a beta of 1.29. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. Option Care Health, Inc. has a 52 week low of $26.11 and a 52 week high of $34.63.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.27 by $0.03. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the company posted $0.63 EPS. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. Analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analysts Set New Price Targets

OPCH has been the topic of several recent analyst reports. Barrington Research boosted their price target on Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. JMP Securities initiated coverage on shares of Option Care Health in a report on Tuesday, July 16th. They set an “outperform” rating and a $36.00 target price on the stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.